老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Armata Pharmaceuticals, Inc.

10.18
-0.3800-3.60%
盘后：10.180.00000.00%16:55 EDT
成交量：2.30万
成交额：24.03万
市值：3.73亿
市盈率：-2.12
高：10.73
开：10.56
低：10.18
收：10.56
52周最高：16.34
52周最低：0.8981
股本：3,663.28万
流通股本：1,087.46万
量比：0.75
换手率：0.21%
股息：- -
股息率：- -
每股收益(TTM):-4.8000
每股收益(LYR):-4.8000
净资产收益率：-3439.35%
总资产收益率：-23.90%
市净率：-1.71
市盈率(LYR):-2.12

数据加载中...

总览公司新闻资讯公告
2020/11/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/06/18

重要事件披露

8-K - Current report
2020/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/04/28

重要事件披露

8-K - Current report
2020/04/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/31

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/30

重要事件披露

Current report, items 3.02, 5.03, 5.07, 8.01, and 9.01
2020/03/19

重要事件披露

Current report, items 2.02 and 9.01
2020/03/19

重要事件披露

Current report, items 1.01, 7.01, and 9.01
2020/03/19

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/26

重要事件披露

Current report, items 5.03 and 9.01
2020/02/14

超过5%披露

General statement of acquisition of beneficial ownership
2020/02/13

重要事件披露

Current report, items 1.01, 3.02, 5.02, 8.01, and 9.01
2020/01/29

重要事件披露

Current report, items 1.01, 3.02, 8.01, and 9.01
2020/01/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/09

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2020/01/09

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
更多